This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
ACTONEL
ALLERGAN PHARMA CO.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ACTONEL discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ACTONEL 5MG has been permanently discontinued (last updated November 28, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ACTONEL
ABBVIE CORPORATION
AURO-RISEDRONATE
AURO PHARMA INC
RISEDRONATE
SIVEM PHARMACEUTICALS ULC
PHL-RISEDRONATE
PHARMEL INC
APO-RISEDRONATE
APOTEX INC
NTP-RISEDRONATE
NT PHARMA CANADA LTD
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02242518
Strength
5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
RISEDRONATE SODIUM
Tier
Unrated
Last Updated
2018-12-20
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
ACTONEL has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from ALLERGAN PHARMA CO.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.